US stocks inch to record high close
US top stocks inched their way out of intraday deficit and closed at fresh record highs on Wednesday after Federal Reserve meeting minutes were released.
Company
Eli Lilly and Co
NYSE:LLY
Eli Lilly and Co is engaged in drug manufacturing businesses. The company discovers, develops, manufactures and markets products in the human pharmaceutical products segment.
147 stories · page 7 of 8
US small-caps among the top risers after Trump victory
US stocks snapped back from initial losses to close Wednesday higher and the Dow even managed an intraday record peak, while small-caps had one of their best days in 14 years, after Donald Trump and the Republicans’ sweep into office
Pharmas Regeneron and Teva shares hit by FDA order
Shares of Regeneron Pharmaceuticals and Teva Pharmaceuticals were hit Monday by news of a clinical trial setback for a new pain drug they are co-developing
Archive
Pfizer, Etsy and eBay on brokers’ radars
Pfizer bruised by a downgrade from Jefferies but Wedbush assume coverage of eCommerce names eBay and Etsy
AstraZeneca's Alzheimer's drug fast-tracked by FDA
BACE inhibitors are the latest glimmer of hope for the treatment of Alzheimer’s disease.
Regen BioPharma, Inc. announced drug discovery agreement with Eli Lilly and Company
Regen will receive compounds from Lilly for drug discovery purposes
AstraZeneca PLC's US$100mln boost as Eli Lilly collaboration moves to next stage
Lilly has made what’s known as a milestone payment following progress in developing a treatment called AZD3293 for early stage Alzheimer's disease.
Archive
AstraZeneca PLC lacks catalysts for 2016 - Jefferies
Broker Jefferies has cut its rating on drugs giant AstraZeneca PLC to 'hold' from 'buy' saying there's a lack of catalysts in 2016 to re-rate shares.
US shares rally to finish mixed
US shares were stabilising but still mixed heading into Tuesday's close.
US shares rally to finish mixed
Heavy losses were pared late in the day and in fact the Dow and the S&P moved into positive territory
Eli Lilly shares take a hit as it cuts EPS guidance
Shares in US drugs giant Eli Lilly & Co fell over 2% in pre-market deals as it cuts its earnings guidance for the 2015 year.
Investments and investor services
US stocks drift lower
Eli Lilly led blue-chips lower after scrapping work on its lead heart drug but news of Ferrari's flotation set petrolheads' pulses racing.
S&P 500 sees gains for the year wiped out
Two-and-a-half days of losses have taken the benchmark index below the level at which it started the year.
Stocks stuck in reverse as Fed falls between two stools
Pundits are no wiser after yesterday's policy statement from the Federal Open Market Committee as to the timing of the long-expected interest rate hike.
Eli Lilly advances after positive results in diabetes study
Shares in Eli Lilly were among the few blue-chips making headway on Thursday after a positive result in a diabetes study.
Investments and investor services
US investors dazed and confused by Fed statement
Pundits are no wiser after yesterday's policy statement from the FOMC as to the timing of the long-expected interest rate hike.
FTSE100 closes lower as Greece election uncertainty surfaces
Pundits are no wiser after yesterday's policy statement as to the timing of the long-expected interest rate hike.